Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers

Fig. 3

Decreased expression of S1PR1 in breast and lung cancer patients (a) Gene expression data of breast invasive carcinoma (BRCA), lung adenocarcinoma (LUAD), and lung squamous cell carcinoma (LUSC) in TCGA were downloaded in UCSC Xena. S1PR1 mRNA expression level was compared between cancerous and normal tissue using Mann-Whitney test with P < 0.05 setting as cut-off. b The expression of S1PR1 in BRCA, LUAD, and LUSC were analysis using GEPIA. T: tumor, N: normal tissue, NUM = number. c–e S1PR1 mRNA expression level was expressed as box plots using the UALCAN database. mRNA expression of S1PR1 in normal control and BRCA, LUAD, and LUSC tumors: (Left) primary tumors, (Right) individual cancer stage. *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page